English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App Credit Cards
Go PRO Now
Open App
Loans
Loans
you are here:

Kotak Healthcare Fund - Regular Plan - IDCW

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : Kotak Mahindra Mutual Fund
  • NAV
    : ₹ 13.788 0.23%
    (as on 19th September, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Fund Size
: ₹ 466.92 Cr
(0.09% of Investment in Category)
 Expense Ratio
: 2.4%
(2.12% Category average)
Risk-O-Meter
Very High Risk

The fund has 95.39% investment in domestic equities of which 30.1% is in Large Cap stocks, 12.78% is in Mid Cap stocks, 7.49% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    NIFTY Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
₹
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 19th September, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 12-Sep-25 10093.00 0.93% - 1.37% 185/239
1 Month 19-Aug-25 10090.00 0.90% - 2.27% 194/237
3 Month 19-Jun-25 10658.60 6.59% - 5.23% 74/229
6 Month 19-Mar-25 10933.30 9.33% - 14.18% 198/225
YTD 01-Jan-25 9600.30 -4.00% - 3.97% 193/214
1 Year 19-Sep-24 10037.90 0.38% 0.38% -0.61% 76/192
Since Inception 12-Dec-23 13788.00 37.88% 19.87% 13.03% 43/218
Returns Calculator Detailed Returns Analysis

SIP Returns (NAV as on 19th September, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 19-Sep-24 12000 12450.88 3.76 % 7.01 %
SIP Calculator Detailed Returns Analysis
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Aug,2025)

Portfolio Turnover Ratio : 31.01%  |   Category average turnover ratio is 154.05%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 95.39% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 95.39%
No of Stocks : 30 (Category Avg - 44.44) | Large Cap Investments : 30.1%| Mid Cap Investments : 12.78% | Small Cap Investments : 7.49% | Other : 45.02%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 605.9 12.98% -1.09% 17.91% (Mar 2025) 12.98% (Aug 2025) 3.80 L -0.20 L
Max Healthcare Institute Ltd. Hospital 352.1 7.54% -0.29% 8.58% (Jun 2025) 3.91% (Nov 2024) 3.05 L 0.00
J.b. Chemicals & Pharmaceuticals Ltd. Pharmaceuticals 277.6 5.95% 0.08% 5.95% (Aug 2025) 3.22% (Sep 2024) 1.61 L 0.00
Cipla Ltd. Pharmaceuticals 270.2 5.79% 0.98% 7.62% (Sep 2024) 4.81% (Jul 2025) 1.70 L 20.00 k
Divis Laboratories Ltd. Pharmaceuticals 245.3 5.25% -0.19% 6.09% (May 2025) 4.83% (Jan 2025) 40.00 k 0.00
Apollo Hospitals Enterprises Ltd. Hospital 201.7 4.32% 0.23% 4.32% (Aug 2025) 3.17% (May 2025) 26.50 k 0.00
Fortis Healthcare Ltd. Hospital 182.3 3.90% 0.72% 3.9% (Aug 2025) 1.85% (Jan 2025) 2.00 L 20.00 k
Lupin Ltd. Pharmaceuticals 180 3.86% 1.00% 3.93% (Sep 2024) 2.86% (Jul 2025) 95.00 k 23.00 k
Jubilant Life Sciences Ltd. Pharmaceuticals 143.2 3.07% -0.37% 4.18% (Oct 2024) 3.04% (Apr 2025) 1.40 L 0.00
Gland Pharma Ltd. Pharmaceuticals 131 2.81% -0.17% 2.98% (Jul 2025) 0% (Sep 2024) 70.00 k 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Detailed Portfolio Analysis
Name Type of Instrument Weight (%)
TREPS TREPS 4.86%
Net Receivables Net Receivables -0.25%
Detailed Portfolio Analysis

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)

    No data available. Ratios are only available for the funds which are 3 years old.

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 389.09 11.12 30.65 54.87 46.98 33.53
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 249.75 3.99 11.91 17.77 26.31 18.55
Franklin Asian Equity Fund - Growth NA 259.99 5.92 13.00 16.09 18.21 12.73
Motilal Oswal Business Cycle Fund - Regular Plan - Growth NA 1976.19 4.99 9.24 15.05 17.81 0.00
Nippon India Japan Equity Fund - Growth NA 283.56 1.67 10.25 13.77 16.38 17.74
Nippon India US Equity Opportunities Fund - Growth NA 713.51 3.56 7.49 10.70 15.32 19.93
Motilal Oswal Manufacturing Fund - Regular Plan - Growth NA 786.43 7.55 9.77 22.45 11.37 0.00
HDFC Transportation and Logistics Fund - Regular Plan - Growth NA 1533.43 6.37 21.68 34.77 11.35 0.00
HDFC Pharma and Healthcare Fund - Regular Plan - Growth NA 1909.30 1.54 8.60 11.90 10.56 0.00
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 8370.76 0.28 2.83 15.38 10.43 17.86

More Funds from Kotak Mahindra Mutual Fund

Out of 120 mutual fund schemes offered by this AMC, 4 is/are ranked 4 * , 16 is/are ranked 3 * , 5 is/are ranked 2 * , 5 is/are ranked 1 * , and 90 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Kotak Arbitrage Fund - Growth 4 72273.57 0.37 1.23 3.12 6.66 7.16
Kotak Midcap Fund - Growth 3 56988.32 2.40 7.13 21.20 4.71 22.03
Kotak Flexi Cap Fund - Growth 4 53625.83 1.41 2.47 14.18 2.86 16.82
Kotak Liquid Fund - Regular Plan - Growth 2 40674.68 0.47 1.43 3.28 6.84 6.95
Kotak Money Market Fund - Growth 3 35644.06 0.46 1.49 4.03 7.77 7.47
Kotak Large & Midcap Fund - Growth 3 27654.67 1.90 4.65 14.28 0.66 18.98
Kotak Multicap Fund - Regular Plan - Growth 3 19227.04 3.38 6.65 17.87 -0.03 23.31
Kotak Bond Short Term Plan - Growth 4 18229.73 0.41 0.90 4.10 7.59 7.14
Kotak Corporate Bond Fund - Growth 3 17612.03 0.50 1.04 4.44 8.08 7.60
Kotak Small Cap Fund - Growth 2 17508.37 1.33 3.23 14.59 -6.21 16.49
All funds

Forum

POST

+ See More

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347